Page de couverture de Eagle's Eye View: Your Weekly CV Update From ACC.org

Eagle's Eye View: Your Weekly CV Update From ACC.org

Eagle's Eye View: Your Weekly CV Update From ACC.org

Auteur(s): American College of Cardiology
Écouter gratuitement

À propos de cet audio

 The weekly cardiovascular update from Kim Eagle, MD, MACC for ACC.org covering the hottest cardiovascular topics, from new clinical guidelines to practice-changing research and innovative quality initiatives and tools.American College of Cardiology Foundation. All rights reserved. Hygiène et mode de vie sain Troubles et maladies
Épisodes
  • Aspirin in PCI; Mavacamten in Nonobstructive Cardiomyopathy; Olezarsen and the Treatment of Hypertriglyceridemia

    Aspirin in PCI; Mavacamten in Nonobstructive Cardiomyopathy; Olezarsen and the Treatment of Hypertriglyceridemia
    Sep 17 2025

    Dr. Eagle continues in this week’s View to analyze some of the key clinical content presented at the ESC Congress recently held in Spain. Dr. Eagle examines the TARGET-FIRST trial in which P2Y12-inhibitor monotherapy was compared to dual antiplatelet therapy (DAPT) in patients who have undergone percutaneous coronary intervention (PCI). He then analyzes the results of the ODYSSEY-HCM trial which explored mavacamten versus placebo in patients with symptomatic nonobstructive hypertrophic cardiomyopathy (HCM). Finally, Dr. Eagle discusses the ESSENCE-TIMI 73b study that looked at olezarsen and its potential for lowering triglycerides in moderate hypertriglyceridemia with elevated cardiovascular risk.

    Subscribe to Eagle’s Eye View

    Voir plus Voir moins
    6 min
  • Aficamten vs. Metoprolol for HCM; Beta Blocks and Myocardial Infarction (MI); Reconditioned Pacemakers for Improving Global CV Health

    Aficamten vs. Metoprolol for HCM; Beta Blocks and Myocardial Infarction (MI); Reconditioned Pacemakers for Improving Global CV Health
    Sep 10 2025

    In this week’s View, Dr. Eagle looks at major trials presented at the recent ESC Congress in Spain. First, he discusses the MAPLE-HCM trial that investigates aficamten versus metoprolol monotherapy in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM). He then explores a set of important presentations on beta blocker therapy following myocardial infarction. Finally, Dr. Eagle talks about new research on the use of reconditioned pacemakers that shows promise for strengthening global cardiovascular health.

    Subscribe to Eagle’s Eye View

    Voir plus Voir moins
    7 min
  • Self-Service Blood Pressure Kiosks; the FLAVOUR Trial & Intermediate Coronary Stenosis; CPAP & Cardiovascular Outcomes

    Self-Service Blood Pressure Kiosks; the FLAVOUR Trial & Intermediate Coronary Stenosis; CPAP & Cardiovascular Outcomes
    Aug 27 2025
    In this week’s View, Dr. Eagle evaluates the potential value of self-service blood pressure (BP) kiosks and their potential to improve hypertensive health nationwide. He then discusses the FLAVOUR trial and its comparable outcomes with fractional flow reserve (FFR) and intravascular ultrasound (IVUS)-guided treatment for intermediate coronary stenosis. Finally, Dr. Eagle explores how continuous positive airway pressure {CPAP} may improve cardiovascular outcomes in patients with high-risk obstructive sleep apnea (OSA). Subscribe to Eagle’s Eye View
    Voir plus Voir moins
    8 min
Pas encore de commentaire